Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2013-04-24

Clinical Trial Update: CO(Mbined Therapy of Malignant) S(Alivary Gland tu)M(Ours With)I(MRT and) c(Arbon Ions): COSMIC [Phase 2]

View source ↗

Summary

Phase 2 COSMIC trial evaluating combined radiotherapy using MRT and carbon ions for malignant salivary gland tumors; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Heidelberg University | Conditions: Malignancy, Salivary Glands | Phase 2 | Status: UNKNOWN